Modulators of IRF4 expression

The present embodiments provide methods, compounds, and compositions useful for inhibiting IRF4 expression, which may be useful for treating, preventing, or ameliorating a cancer associated with IRF4.

Saved in:
Bibliographic Details
Main Authors Zhou, Tianyuan, MacLeod, Robert, Kim, Youngsoo, Bui, Huynh-Hoa, Freier, Susan M
Format Patent
LanguageEnglish
Published 23.07.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present embodiments provide methods, compounds, and compositions useful for inhibiting IRF4 expression, which may be useful for treating, preventing, or ameliorating a cancer associated with IRF4.
Bibliography:Application Number: US202117554558